Evidence map›Paper›PMID 29084270›Full record

ArticlePLoS pathogens2017

Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors.

Massiel Cepeda-Molero, Cedric N Berger, Alistair D S Walsham, Samuel J Ellis, Simon Wemyss-Holden, Stephanie Schüller, Gad Frankel, Luis Ángel Fernández

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Explainable AI-SERS approach for highly accurate discrimination ofCurrent research in microbial sciences · 2026
    Article
  4. Review
  5. Article
  6. Complete deletion of theInfection and immunity · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Hybrid genome assemblies of four Shiga toxin-producingMicrobiology resource announcements · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Lymphostatin, a virulence factor of attaching and effacingFrontiers in cellular and infection microbiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Massiel Cepeda-MoleroDepartment of Microbial Biotechnology. Centro Nacional de Biotecnología, CNB-CSIC. Darwin 3, Campus UAM, Cantoblanco, Madrid, Spain.
Cedric N BergerMRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.
Alistair D S WalshamNorwich Medical School, University of East Anglia, Norwich, United Kingdom.
Samuel J EllisNorwich Medical School, University of East Anglia, Norwich, United Kingdom.ORCID http://orcid.org/0000-0002-5012-4277
Simon Wemyss-HoldenDepartment of Surgery, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom.
Stephanie SchüllerNorwich Medical School, University of East Anglia, Norwich, United Kingdom.ORCID http://orcid.org/0000-0003-3260-9112
Gad FrankelMRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.
Luis Ángel FernándezDepartment of Microbial Biotechnology. Centro Nacional de Biotecnología, CNB-CSIC. Darwin 3, Campus UAM, Cantoblanco, Madrid, Spain.ORCID http://orcid.org/0000-0001-5920-0638
University of East Anglia · GBCentro Nacional de Biotecnología · ESImperial College London · GBNorfolk and Norwich University Hospital · GB

Funding

Medical Research Council MR/J002062/1Medical Research Council MR/P028225/1Wellcome Trust
6 · The paper itself

Abstract

Enteropathogenic E. coli (EPEC) is a human pathogen that causes acute and chronic pediatric diarrhea. The hallmark of EPEC infection is the formation of attaching and effacing (A/E) lesions in the intestinal epithelium. Formation of A/E lesions is mediated by genes located on the pathogenicity island locus of enterocyte effacement (LEE), which encode the adhesin intimin, a type III secretion system (T3SS) and six effectors, including the essential translocated intimin receptor (Tir). Seventeen additional effectors are encoded by genes located outside the LEE, in insertion elements and prophages. Here, using a stepwise approach, we generated an EPEC mutant lacking the entire effector genes (EPEC0) and intermediate mutants. We show that EPEC0 contains a functional T3SS. An EPEC mutant expressing intimin but lacking all the LEE effectors but Tir (EPEC1) was able to trigger robust actin polymerization in HeLa cells and mucin-producing intestinal LS174T cells. However, EPEC1 was unable to form A/E lesions on human intestinal in vitro organ cultures (IVOC). Screening the intermediate mutants for genes involved in A/E lesion formation on IVOC revealed that strains lacking non-LEE effector/s have a marginal ability to form A/E lesions. Furthermore, we found that Efa1/LifA proteins are important for A/E lesion formation efficiency in EPEC strains lacking multiple effectors. Taken together, these results demonstrate the intricate relationships between T3SS effectors and the essential role non-LEE effectors play in A/E lesion formation on mucosal surfaces.

Indexed as

Adhesins, BacterialCarrier ProteinsEnterocytesEscherichia coliGene Expression Regulation, BacterialGenomic IslandsHumansIntestinal MucosaAdhesins, BacterialCarrier Proteins

Identifiers

PMID29084270
PMCPMC5685641
OpenAlexW2767113588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.